Author:
Wang Juan,Zhang Ning,Li Baosheng,Wang Zhongtang,Sun Hongfu,Yi Yan,Huang Wei
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Ihde DC, Bunn PA, Hansen HH. Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer: how useful are they? J Clin Oncol. 1997;8:2996–3018.
2. Gridelli C, Rossi A, Maione P. Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents. Oncogene. 2003;22:6629–38.
3. Ebert W, Muley T. CYFRA 21–1 in the follow-up of inoperable non-small cell lung cancer patients treated with chemotherapy. Anticancer Res. 1999;19:2669–72.
4. van der Gaast A, Kok TC, Kho GS, Blijenberg BG, Splinter TAW. Disease monitoring by tumour markers cyfra 21–1 and TPA in patients with non small cell lung cancer. Eur J Cancer. 1995;31A:1790–3.
5. Werner-Wasik M, Xiao Y, Pequignot E, Curran WJ, Hauck W. Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study. Int J Radiat Oncol Biol Phys. 2001;51:56–61.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献